BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12142739)

  • 21. Cyclic GMP does not inhibit protein kinase C-mediated enzyme secretion in rat pancreatic acini.
    Menozzi D; Sato S; Jensen RT; Gardner JD
    J Biol Chem; 1989 Jan; 264(2):995-9. PubMed ID: 2463255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of pancreatic exocrine function in Otsuka Long-Evans Tokushima Fatty (OLETF) rats without gene expression of cholecystokinin-A receptor.
    Funakoshi A; Miyasaka K; Shinozaki H; Arita Y; Nakano I; Nawata H
    Intern Med; 1996 Apr; 35(4):249-56. PubMed ID: 8739776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
    Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M
    Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic polypeptide inhibits amylase release by rat pancreatic acini.
    Joehl RJ; DeJoseph MR
    J Surg Res; 1986 Apr; 40(4):310-4. PubMed ID: 2422440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
    Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
    Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin-induced regulation of muscarinic receptor on dispersed pancreatic acini.
    Aoki E; Adachi H; Noguchi M; Honda T; Sato S; Onishi S; Katsushima S; Konishi J
    Gastroenterol Jpn; 1990 Oct; 25(5):598-606. PubMed ID: 1699831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 inhibits secretagogue-induced enzyme secretion from rat pancreatic acini.
    Mössner J; Secknus R; Spiekermann GM; Sommer C; Biernat M; Bahnsen H; Fischbach W
    Am J Physiol; 1991 May; 260(5 Pt 1):G711-9. PubMed ID: 1709788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
    Taniguchi H; Nagasaki M; Tamaki H
    Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-affinity CCK-1 receptors inhibit bombesin-stimulated secretion in rat pancreatic acini--implication of the actin cytoskeleton.
    Kiehne K; Herzig KH; Otte JM; Fölsch UR
    Regul Pept; 2002 May; 105(2):131-7. PubMed ID: 11891013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a cholecystokinin analogue with partial agonist activity.
    Howard JM; Knight M; Jensen RT; Gardner JD
    Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of cholecystokinin and vasoactive intestinal polypeptide on function of mouse pancreatic acini in vitro.
    Burnham DB; McChesney DJ; Thurston KC; Williams JA
    J Physiol; 1984 Apr; 349():475-82. PubMed ID: 6204039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbachol does not down-regulate substance P receptors in pancreatic acini.
    Patto RJ; Vinayek R; Jensen RT; Gardner JD
    Pancreas; 1992; 7(4):447-52. PubMed ID: 1379366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbachol desensitizes pancreatic enzyme secretion by downregulation of receptors.
    Vinayek R; Murakami M; Sharp CM; Jensen RT; Gardner JD
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G107-21. PubMed ID: 1689117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-affinity cholecystokinin type A receptor/cytosolic phospholipase A2 pathways mediate Ca2+ oscillations via a positive feedback regulation by calmodulin kinase in pancreatic acini.
    Lankisch TO; Nozu F; Owyang C; Tsunoda Y
    Eur J Cell Biol; 1999 Sep; 78(9):632-41. PubMed ID: 10535305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic neuromedin C stimulates exocrine pancreatic secretion in dogs and rats.
    Hosotani R; Inoue K; Kogire M; Suzuki T; Otsuki M; Rayford PL; Yajima H; Tobe T
    Pancreas; 1987; 2(4):414-21. PubMed ID: 2442749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,2-Diacylglycerol, protein kinase C, and pancreatic enzyme secretion.
    Pandol SJ; Schoeffield MS
    J Biol Chem; 1986 Apr; 261(10):4438-44. PubMed ID: 2420788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogens influence cholecystokinin stimulated pancreatic amylase release and acinar cell membrane cholecystokinin receptors in rat.
    Blevins GT; Huang HS; Tangoku A; Mckay DW; Rayford PL
    Life Sci; 1991; 48(16):1565-74. PubMed ID: 1708070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin (CCK)-induced desensitization of pancreatic enzyme secretion is mediated by low affinity CCK receptors.
    Menozzi D; Stark HA; Martinez J; Jensen RT; Gardner JD
    Peptides; 1989; 10(2):337-41. PubMed ID: 2474153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbachol acts through protein kinase C to modulate cholecystokinin receptors on pancreatic acini.
    Louie DS; Chung OY
    Am J Physiol; 1991 Dec; 261(6 Pt 1):G981-6. PubMed ID: 1722647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.